News summary

Engineering signal transduction for closed-loop gene and cell therapies

Source: Nature - Biotechnology • Published: 17 Nov 2026, 00:00

Summarized by Masters of Longevity from Nature - Biotechnology.

Engineered gene circuits sense disease signals and adjust therapy autonomously.

Engineering signal transduction for closed-loop gene and cell therapies
Key Takeaways
  • Setpoint medicine is designed to keep physiology within targets.
  • Programmable signal transduction is reported to route inputs into outputs.
  • Clinical translation has not established durable circuits and safety metrics.
Read the full article at Nature - Biotechnology ↗

Continue exploring

Recommended MoL Picks

MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickFrom Metrics to Better LivingEverstride’s May 2026 Consumer Health Market Briefing shows a wellness market moving from products to systems, from tracking to guidance, and from optimization to meaning. The next winners in longevity may not be the companies that measure the most. They may be the ones that help consumers translate health data into a life they actually want to live.MoL PickNucleotides and Longevity: Is the Evidence Ready?They help build DNA and keep cells working. Early human studies make nucleotide supplements interesting—but leave important questions about healthy ageing unanswered. Yet.